AerCap Holdings (AER) Prices $750M Notes Offering

AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust (together, the "Issuers"), each a wholly-owned subsidiary of AerCap Holdings N.V. ("AerCap" or the "Company"), priced an offering of $750 million aggregate principal amount of the Issuers' Fixed-Rate Reset Junior Subordinated Notes due 2055 (the "Notes"). The Notes will be issued with an initial interest rate of 6.950% per annum, to be reset on March 10, 2030 and every five years thereafter based on the then-prevailing five-year U.S. Treasury rate plus a spread of 2.720%. The Notes will be fully and unconditionally guaranteed on an unsecured junior subordinated basis by the Company and certain other subsidiaries of the Company.

The Issuers intend to use the net proceeds from the Notes for general corporate purposes, which may include the redemption of all or a portion of the Company's outstanding Fixed-Rate Reset Junior Subordinated Notes due 2079 (the "2079 Junior Subordinated Notes") on October 10, 2024, which is the first call date in respect of such notes. The information contained in this press release does not constitute a notice of redemption for the 2079 Junior Subordinated Notes.

J.P. Morgan, Mizuho, Goldman Sachs & Co. LLC and Santander are serving as joint book-running managers for the underwritten public offering.

The Company has filed a registration statement (including a prospectus) on Form F-3 with the U.S. Securities and Exchange Commission (the "SEC") for the underwritten offering to which this communication relates. The registration statement automatically became effective upon filing on October 19, 2021. Investors should read the accompanying prospectus dated October 19, 2021, the preliminary prospectus supplement relating to the offering dated July 8, 2024, and other documents the Company has filed with the SEC for more complete information about the Company and this offering.

These documents may be obtained for free by visiting EDGAR on the SEC's website at www.sec.gov. The prospectus supplement and accompanying prospectus relating to this offering may also be obtained from: J.P. Morgan Securities LLC, Attn: Investment Grade Syndicate Desk, 383 Madison Avenue, New York, New York 10179, by facsimile at 212-834-6081; Mizuho Securities USA LLC, Attn: Debt Capital Markets, 1271 Avenue of the Americas, New York, New York 10020, or by calling toll-free at 1-866-271-7403; Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at 1-866-471-2526, by facsimile at 212-902-9316, or by emailing [email protected]; or Santander US Capital Markets LLC, 437 Madison Avenue, New York, New York 10022, by telephone at 1-855-403-3636, or by email at [email protected].

This press release shall not constitute an offer to sell or purchase or the solicitation of an offer to sell or purchase the Notes, the 2079 Junior Subordinated Notes or any other securities, nor shall there be any offer, solicitation, purchase or sale of these securities in any state or jurisdiction in which such offer, solicitation, purchase or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Cosmos Health signs Saudi distribution deal for supplement line
• bioAffinity Technologies sets 1-for-15 reverse stock split Aug. 24
• Niagen Bioscience's Tru Niagen now sold at GNC and Sam's Club